Increased secretory leukocyte protease inhibitor (SLPI) production by highly metastatic mouse breast cancer cells.
The precise molecular mechanisms enabling cancer cells to metastasize from the primary tumor to different tissue locations are still largely unknown. Secretion of some proteins by metastatic cells could facilitate metastasis formation. The comparison of secreted proteins from cancer cells with diffe...
Saved in:
| Main Authors: | Kevin T Sayers, Alan D Brooks, Thomas J Sayers, Oleg Chertov |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2014-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://doi.org/10.1371/journal.pone.0104223 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The effect of secretory leukocyte protease inhibitor amnion membrane on incisional wound healing
by: Elly Munadziroh, et al.
Published: (2022-05-01) -
Secretory leukocyte protease inhibitor influences periarticular joint inflammation in Borrelia burgdorferi-infected mice
by: Qian Yu, et al.
Published: (2025-05-01) -
Secretory leukocyte protease inhibitor in oral potentially malignant disorders and oral squamous cell carcinoma
by: Vidya Ajila, et al.
Published: (2019-01-01) -
Secretory leucocyte protease inhibitor regulates bone metabolism and inflammation in experimental mouse periodontitis
by: Karin Sasagawa, et al.
Published: (2025-05-01) -
The Role of <i>SLPI</i> Gene-Mediated Inflammation in Osteoarthritis
by: Mahmuda Siddika Shefa, et al.
Published: (2025-06-01)